Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY Endovascular Robotic System, today ...
Image-guided care is changing how physicians treat disease without large incisions or lengthy hospital stays. Using ultrasound, CT, MRI, or fluoroscopy, specialists guide needles, wires, and catheters ...
New Jersey Urology will soon begin providing image guided procedures for enlarged prostates and other clinical concerns ...
An international phase 3 clinical trial that treated patients with high-risk localized and locally advanced prostate cancer ...
An international phase 3 clinical trial that treated patients with high-risk localized and locally advanced prostate cancer ...
Adding abiraterone to standard treatment provides a lasting survival benefit for men whose prostate cancer has already spread ...
A 66-year-old man with prostate cancer had his tumor removed without the surgeon ever stepping into his operating room. Dr.
An international phase 3 clinical trial that treated patients with high-risk localized and locally advanced prostate cancer ...
Briganti and colleagues concluded that, together with the main PROTEUS study, the substudy supports 1-year perioperative apalutamide plus ADT as a treatment option for patients with high-risk ...
Landmark results from the DeLLphi-305 Phase III trial showed IMFINZI® (durvalumab) plus Amgen’s tarlatamab-dlle demonstrated a statistically significant and highly clinically meaningful improvement in ...
Patients with persistent blood clots require frequent medical interventions just to survive. Yet despite this critical need, ...
Positive results from the VOLGA Phase III trial showed perioperative treatment with AstraZeneca’s IMFINZI® (durvalumab) in combination with neoadjuvant enfortumab vedotin (EV) demonstrated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results